Moreover, in lung cancer cells, gal-3 silencing increased drug sensitivity to cisplatin and paclitaxel by regulating the ABCB1 and ABCG2 transporter pumps through β-catenin [62]. This evidence concerns the gene ABCB1 and lung cancer.